Straker Translations Ltd
ASX:STG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Straker Translations Ltd
ASX:STG
|
NZ |
|
A
|
Assam Entrade Ltd
BSE:542911
|
IN |
|
H
|
Hinge Health Inc
NYSE:HNGE
|
US |
|
H
|
Hitech Corporation Ltd
NSE:HITECHCORP
|
IN |
|
S
|
Sinotherapeutics Inc
SSE:688247
|
CN |
|
H
|
Hugo Boss AG
OTC:BOSSY
|
DE |
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Tata Steel Ltd
NSE:TATASTEEL
|
IN |
Income Statement
Earnings Waterfall
Straker Translations Ltd
Income Statement
Straker Translations Ltd
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
28
N/A
|
29
+4%
|
31
+8%
|
40
+27%
|
56
+40%
|
66
+17%
|
59
-9%
|
52
-13%
|
50
-4%
|
47
-6%
|
45
-5%
|
41
-8%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(13)
|
(14)
|
(15)
|
(18)
|
(26)
|
(30)
|
(26)
|
(21)
|
(18)
|
(16)
|
(15)
|
(14)
|
|
| Gross Profit |
15
N/A
|
15
+1%
|
17
+9%
|
22
+33%
|
30
+37%
|
36
+17%
|
34
-5%
|
31
-8%
|
32
+3%
|
32
-1%
|
30
-5%
|
28
-8%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(19)
|
(19)
|
(21)
|
(29)
|
(37)
|
(40)
|
(40)
|
(37)
|
(34)
|
(36)
|
(35)
|
(31)
|
|
| Selling, General & Administrative |
(16)
|
(18)
|
(18)
|
(27)
|
(30)
|
(33)
|
(25)
|
(29)
|
(20)
|
(28)
|
(18)
|
(24)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(5)
|
(10)
|
(9)
|
(8)
|
(8)
|
(8)
|
(7)
|
|
| Depreciation & Amortization |
(2)
|
(1)
|
(3)
|
(2)
|
(7)
|
(2)
|
(5)
|
0
|
(7)
|
0
|
(9)
|
0
|
|
| Other Operating Expenses |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
|
| Operating Income |
(4)
N/A
|
(4)
0%
|
(4)
-8%
|
(7)
-73%
|
(6)
+4%
|
(5)
+26%
|
(6)
-24%
|
(6)
-6%
|
(2)
+61%
|
(4)
-62%
|
(5)
-18%
|
(4)
+22%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
2
|
(0)
|
(2)
|
(2)
|
(2)
|
6
|
2
|
(1)
|
1
|
(1)
|
1
|
2
|
|
| Non-Reccuring Items |
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(3)
|
(3)
|
(7)
|
(5)
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
2
|
1
|
1
|
1
|
2
|
1
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(5)
-87%
|
(6)
-23%
|
(9)
-50%
|
(6)
+32%
|
2
N/A
|
(3)
N/A
|
(6)
-124%
|
(2)
+59%
|
(7)
-188%
|
(10)
-47%
|
(6)
+41%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(5)
|
(6)
|
(9)
|
(6)
|
2
|
(3)
|
(6)
|
(2)
|
(7)
|
(10)
|
(6)
|
|
| Net Income (Common) |
(3)
N/A
|
(5)
-91%
|
(6)
-25%
|
(9)
-50%
|
(6)
+34%
|
2
N/A
|
(3)
N/A
|
(6)
-110%
|
(2)
+62%
|
(7)
-201%
|
(10)
-54%
|
(6)
+40%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.09
-80%
|
-0.11
-22%
|
-0.15
-36%
|
-0.09
+40%
|
0.02
N/A
|
-0.04
N/A
|
-0.08
-100%
|
-0.03
+63%
|
-0.1
-233%
|
-0.16
-60%
|
-0.09
+44%
|
|